WHO COOPERATIVE TRIAL ON PRIMARY PREVENTION OF ISCHAEMIC HEART DISEASE WITH CLOFIBRATE TO LOWER SERUM CHOLESTEROL: FINAL MORTALITY FOLLOW-UP: Report of the Committee of Principal Investigators☆
References (5)
A cooperative trial in the prevention of ischaemic heart disease using clofibrate
Br Heart J
(1978)WHO cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up
Lancet
(1980)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
Report prepared by Prof. M. F. OLIVER, Dr. J. A. HEADY, Prof. J. N. MORRIS, and Ms. J. COOPER. Principal investigators: I. Gyarfas, Hungarian Institute of Cardiology, Budapest (G. Lamm 1966–74); J. Widimsky, Institute for Clinical and Experimental Medicine, Prague (H. Geizerova 1968–1980; J. Fodor, 1966–68); K. G. Green, ICI, Macclesfield; J. A. Heady, Medical Research Council, Royal Free Hospital School of Medicine, London; G. Lamm, Ruprecht-Karls-Universitat, Heidelberg (WHO, Copenhagen 1974–81); J. N. Morris, Medical Research Council, London School of Hygiene and Tropicla Medicine; M. F. Oliver, Royal Infirmary, Edinburgh; T. Strasser, WHO, Geneva, 1973–83 (Z. Fejfar 1966–73).
Copyright © 1984 Published by Elsevier Ltd.